Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- to assess the efficacy of the combination in terms of Objective (clinical and
radiological) Response Rate
- to assess the time to progression of the disease; assess the safety profile of the
combination, and assess the survival time.